Posts Tagged ‘sarcoma cancer’
If you have ever received a sarcoma diagnosis, our colleagues at The Cancer Support Community need your help. Read their message below to learn how you can share your thoughts on what matters most to those living with cancer. Subject: Help us understand what matters most to people with cancer! The Cancer Support Community (CSC) is looking for people to help develop a new tool to understand what matters most to people living with cancer. Please consider participating if you have ever received a cancer diagnosis, are at least 18 years old, and can read English. Participants who complete the survey… Read More »
Sarcoma is a rare type of cancer and typically produces malignant tumors derived from the connective tissue. There are more than 70 sarcoma types and subtypes. Soft Tissue Sarcoma Soft tissue sarcoma broadly defines cancers that develop in the body’s soft tissues (i.e. muscles, tendons, fat, lymph vessels, blood vessels, and nerves). While these cancers are most commonly found in the head, neck, arms, legs, chest, and abdomen, they can develop anywhere in the body. There are various different types of soft tissue sarcoma, and depending on the type of soft tissue the cancer started in, the cells will look… Read More »
DAMASCUS, Md. – June 27, 2019 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research and awareness for sarcoma, today announced that it has awarded three quarters of a million dollars in research funds to deserving scientists as part of its 2019 SFA Research Grant program. Fifteen research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the… Read More »
DAMASCUS, Md. – November 1, 2018 – The Sarcoma Foundation of America (SFA), the leading organization dedicated to increased research and awareness for sarcoma, today announced two research grants awarded to projects focused on the study of uterine leiomyosarcoma. Uterine leiomyosarcoma is a rare subtype of sarcoma, a cancer that occurs in soft tissue and bone. Made possible by the generosity of the Dr. Richard and Valerie Aronsohn Memorial Fund, these awards support investigative efforts by leading sarcoma researchers at Memorial Sloan-Kettering Cancer Center and Stanford University. These research projects are eligible for renewal, potentially bringing the SFA’s overall investment… Read More »
DAMASCUS, Md. – May 10, 2018 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research and awareness for sarcoma, today announced that it has awarded half a million dollars in research funds to deserving scientists as part of its 2018 SFA Research Grant program. Ten research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the best, most… Read More »
Kenneth Cardona, MD, FACS, Associate Professor of Surgery, Winship Cancer Institute at Emory University Race to Cure Sarcoma™ Atlanta What inspired you to specialize in sarcoma? The rarity and complexity of this disease in combination with our limited treatment options outside of surgical therapy inspired me to focus my advanced surgical training in surgical oncology on this unique disease. What is the focus of the research performed in your lab? I am the lead and principal investigator of the Unites States Sarcoma Collaborative, which is a multi-institutional research effort amongst 8 academic institutions across the US studying this rare… Read More »
DAMASCUS, Md. – March 1, 2018 – The Sarcoma Foundation of America (SFA) today announced that renown orthopedic surgeon James C. Wittig, MD, is the 2018 recipient of the organization’s prestigious Nobility in Science Award. Dr. Wittig is being recognized for his contributions to sarcoma cancer research, treatment, education, and advocacy during a ceremony at the SFA’s 16th Annual fundraising event, Stand Up to Sarcoma, on Thursday, May 3, 2018, at Guastavino’s in Manhattan. The Nobility in Science Award is given to an outstanding scientist who is dedicated to the advancement of knowledge of sarcoma and works tirelessly to find new… Read More »
Excitement for the 2018 Race to Cure Sarcoma™ season is building as we head into what will no doubt be our biggest and best year yet! The Race to Cure Sarcoma™ remains the premier run/walk series in the United States focused on raising awareness and research funds for sarcoma. Organized by the Sarcoma Foundation of America (SFA), the Race to Cure Sarcoma™ is made up of family-friendly 5K run/walks held in cities across the nation. Last year, nearly 3,500 people participated in the Race to Cure Sarcoma™. What makes the 2018 Race to Cure Sarcoma™ so exciting? … Read More »
William K. Decker, PhD, Associate Professor, Baylor College of Medicine 2016 Pittsburgh Cure Sarcoma Co-Founder Carl Firetto Memorial Research Award: “Outbred Canine Model of Adjuvant Immunotherapy for Angiosarcoma” PLEASE DESCRIBE THE FOCUS OF THE RESEARCH PERFORMED IN YOUR LAB. We study the basic immunobiology of dendritic cells and the manner by which this critical cell subtype orchestrates TH polarization. TH polarization sounds complicated – and it is – but can be explained relatively easily. The adaptive immune system makes two main types of fundamentally different immune responses. One of these responses, termed TH2, is aimed at eliminating pathogens that… Read More »
UPDATE: On March 22, 2018, The United States Senate passed the STAR Act! Now the legislation moves on to the House for consideration. Please contact your Representative to ask them to pass the STAR Act. We need your help! Time is running out for Congress to take up The Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act. The STAR Act would expand opportunities for childhood cancer research, improve efforts to identify and track childhood cancer incidences, enhance the quality of life for childhood cancer survivors, and ensure publicly accessible expanded access policies that provide hope for patients… Read More »
Today’s post was written by Sara Jade Alan, a sarcoma survivor and author. On the evening of November 17, at Smoky Hill High School, Colorado’s first-ever Teen Comedy Contest was held. In a cafeteria transformed by talented teen techies into a theater space complete with stage lighting, over fifty students from six high school improv troupes around the Denver metro area gathered together. They brought their energy, excitement, and chops for making-stuff-up-on-the-spot, all to benefit a great cause…and to compete for improv glory. With troupe names like the Flustered Mustards (Heritage HS), Method to Madness (Cherokee Trail HS), Regular Irregulars (East… Read More »
Today’s post was written by Sara Jade Alan, a sarcoma survivor and author. In 2005, I was in my twenties and living and performing comedy in New York City. I had just completed an eight-month yoga-teacher training program when I discovered a lump on my outer left thigh. I thought it would be nothing, but I went to see an orthopedic doctor about it to make sure. He coolly told me: tumor. I remember walking out of his office onto the blustery NYC street, the giant X-ray envelope whipping around in my hands like a sail—as if to warn, the… Read More »
Andrew Koff, PhD, Member and Professor, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center 2014 Heidi Connery Memorial Research Grant: “Proteomic and genomic approaches to understanding intrinsic and acquired resistance to CDK4 inhibition therapy in well differentiated/dedifferentiated liposarcoma” PLEASE DESCRIBE THE FOCUS OF THE RESEARCH PERFORMED IN YOUR LAB. The laboratory of cell cycle regulation at Memorial Sloan Kettering Cancer Center is interested in identifying the genes and proteins that regulate the transition of cells from quiescence, a reversible type of proliferative exit, to senescence, a more stable irreversible type of proliferative exit. Proliferation associated with a deregulated cell cycle… Read More »
The results of our 2017 Children’s Sarcoma Artwork Contest are in and it’s a tie! Congratulations to both Alli and Ellie, 11-year-old twins. They created their pieces in memory of their beloved brother, Brice. Brice passed away from Epithelioid Sarcoma. Alli’s artwork will be featured on the SFA’s 2017 holiday card. Ellie’s work will be used for new SFA note cards. Both Alli and Ellie’s artwork is now featured in our SFA shop! Visit http://www.cafepress.com/curesarcoma and click on the “Children’s Artwork” tab to see the newest merchandise with Alli and Ellie’s designs. Thank you again to everyone who submitted their art. All… Read More »
DAMASCUS, Md. – May 24, 2017 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased awareness and research for sarcoma, today announced that it has awarded $500,000 in research funds to deserving scientists at institutions across the United States as part of its 2017 SFA Research Grant program. Ten research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a rare cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the… Read More »
Today’s post was written by Bert E. Thomas IV, PhD, MBA, CEO of the Sarcoma Foundation of America. This is my last week at the Sarcoma Foundation of America (SFA). Over the last three years it has been my privilege to serve the sarcoma patient community through my role at the SFA. I have meet so many amazing patients, caregivers, doctors and researchers in that time. I have been moved by the challenges that each face, the perseverance that they demonstrate in their individual and collective efforts to achieve better patient outcomes, and the hope and optimism that the sarcoma community… Read More »
Today’s blog was written by Caleigh during her time at the Sarcoma Foundation of America’s office for “Take Your Child to Work” day. Caleigh, a 3rd grader, is the daughter of Lori Hoffman, SFA’s Senior Manager of Public Policy and External Affairs. This is Caleigh’s third year helping out at the SFA. Last year, she wrote a blog about how kids can help in our efforts to raise money for sarcoma research. She has once again chosen to serve as a guest blogger during her time in the office. By Caleigh Have you ever wondered about the Sarcoma Foundation of… Read More »
Today’s post was written by Bert E. Thomas IV, PhD, MBA, CEO of the Sarcoma Foundation of America. In the three years that I have been with the Sarcoma Foundation of America, I have had the privilege of serving the sarcoma community. An important part of my job as CEO is to meet patients, caregivers and loved ones, learn about their patient journeys, and try to understand the challenges that each and every sarcoma patient deals with on their path to becoming a sarcoma survivor. I have also worked closely with sarcoma doctors and researchers, learning about their efforts to… Read More »
– Vision of Hope Award to be presented at the SFA’s 15th Annual Fundraising Gala – DAMASCUS, Md. – April 10, 2017– The Sarcoma Foundation of America (SFA), an organization dedicated to increased research funding and advocacy for sarcoma, is pleased to announce that Lilly Oncology is the 2017 recipient of the Vision of Hope Award. Lilly Oncology will be honored at the SFA’s 15th Annual New York fundraising gala, “A Celebration of Life.” The event will take place on April 20, 2017, at Guastavino’s, 409 E 59th Street, New York, NY. The Vision of Hope Award is presented… Read More »
Today’s post was written by Bert E. Thomas IV, PhD, MBA, CEO of the Sarcoma Foundation of America. Two years ago, I wrote a blog post in honor of Rare Disease Day. Entitled, “Shedding Light on the Forgotten Cancer,” it was a piece meant to raise awareness for a little known disease on a day designed to bring attention to a community of patients that are so often overlooked. It seems appropriate to share that post again as we are near Rare Disease Day 2017. On the last day of February, the rare disease community will collectively join voices and… Read More »
Today’s post was written by Bert E. Thomas IV, PhD, MBA, CEO of the Sarcoma Foundation of America. There was a long period of time where there seemed to be little to no progress in finding ways to battle the forgotten cancer known as sarcoma. This period of time lasted for decades, though it probably felt more like centuries to the patients and families that were desperately looking for treatment options that never seemed to come. And while sarcoma still takes too many of our loved ones from us, progress in our fight against this terrible disease is finally being… Read More »
The Sarcoma Foundation of America recently launched a new Public Service Announcement (PSA) campaign. The campaign, named “Sarcoma is Cancer,” is designed to educate a broader audience about sarcoma, introducing many listeners to this rare cancer for the very first time. These PSAs have already begun airing on radio stations across the United States, with more stations slated to run the ads before the end of the year. Listen to the PSAs: “Sarcoma is Cancer” 60 Second PSA “Sarcoma is Cancer” 30 Second PSA The PSAs are also available at www.curesarcoma.org/sfa-in-the-news/. You can be a part of the effort to raise… Read More »
Today’s post was written by Bert E. Thomas IV, PhD, MBA, CEO of the Sarcoma Foundation of America. As I write my last blog for the year, I can’t help but to think about the time of year and what it means for everyone. The Holiday Season is a time of hope and renewal, a time to spend with family and friends, and time to celebrate the special moments and accomplishments of the year. It is also a time to embrace the hope and excitement of the new year. With that said, I’d like to share with you the outcomes of… Read More »
UPDATE 12/9/2016: Thank you to all of the advocates who reached out to their Senators to urge passage of the STAR Act. Unfortunately, a vote in the Senate will not take place this year. This is not the end, as the effort will begin again in 2017. UPDATE: On December 6, 2016, the US House of Representatives passed the STAR Act. Now the US Senate must act before they adjourn at the end of this week! We need your help to make this happen. You can take action by: Calling your Senator and asking them to pass the STAR… Read More »
The Sarcoma Foundation of America (SFA) is joining with other cancer advocacy organizations through the One Voice Against Cancer (OVAC) alliance for a Twitter action day on Tuesday, December 6. The point of this action day is to urge Members of Congress to include the Cancer Moonshot funding provided from the 21st Century Cures Act in a FY 2017 Continuing Resolution (CR). It is critical that we make every effort to ensure that the funds for the Cancer Moonshot are included in the CR so that the research proposals in the Blue Ribbon Panel report can be funded without further delay. We… Read More »